Form 8-K - Current report:
SEC Accession No. 0001279569-23-000954
Filing Date
2023-07-31
Accepted
2023-07-31 15:52:50
Documents
14
Period of Report
2023-07-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fourfront8k.htm   iXBRL 8-K 29083
2 NEWS RELEASE DATED JULY 28, 2023 ex991.htm EX-99.1 13337
3 GRAPHIC logo.jpg GRAPHIC 8404
  Complete submission text file 0001279569-23-000954.txt   231140

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20230728.xsd EX-101.SCH 3094
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20230728_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20230728_pre.xml EX-101.PRE 22372
8 EXTRACTED XBRL INSTANCE DOCUMENT fourfront8k_htm.xml XML 3166
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 231127265
SIC: 2833 Medicinal Chemicals & Botanical Products